
    
      The ELEVATE study is a prospective, multi-center, single-arm trial of the Pipeline™ Shield
      Device for the treatment of adults with acutely ruptured intracranial aneurysms. The primary
      objective of the ELEVATE study is to assess the safety and effectiveness of treatment with
      the Pipeline™ Shield Device of acutely ruptured intracranial aneurysms that are not amenable
      for clipping and coiling.
    
  